(19)
(11) EP 1 805 180 A1

(12)

(43) Date of publication:
11.07.2007 Bulletin 2007/28

(21) Application number: 05810272.4

(22) Date of filing: 20.10.2005
(51) International Patent Classification (IPC): 
C07D 473/04(2006.01)
A61K 31/522(2006.01)
C07D 473/06(2006.01)
A61P 9/00(2006.01)
(86) International application number:
PCT/EP2005/011376
(87) International publication number:
WO 2006/045565 (04.05.2006 Gazette 2006/18)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated Extension States:
HR

(30) Priority: 22.10.2004 GB 0423568
10.12.2004 GB 0427079

(71) Applicant: SMITHKLINE BEECHAM CORPORATION
Philadelphia, PA 19101 (US)

(72) Inventors:
  • HATLEY, Richard Jonathan Daniel, GlaxoSmithKline
    Stevenage Hertfordshire SG1 2NY (GB)
  • PINTO, Ivan Leo, GlaxoSmithKline
    Stevenage Hertfordshire SG1 2NY (GB)

(74) Representative: Reed, Michael Antony et al
GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) XANTHINE DERIVATIVES WITH HM74A RECEPTOR ACTIVITY